A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 103
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PASS
Long Form : patient acceptable symptom state
No. Year Title Co-occurring Abbreviation
2019 Ability of Patient-Reported Outcomes to Characterize Patient Acceptable Symptom State (PASS) After Attending a Primary Care Physical Therapist and Medical Doctor Collaborative Service: A Cross-Sectional Study. AUC, GRNF, PROMIS
2019 Disease activity and functional status associated with health-related quality of life and patient-acceptable symptom state in patients with psoriatic arthritis in Thailand: A cross-sectional study. cDAPSA, DAPSA, EQ-5D-5L, HAQ, HU, MDA, PsA
2019 Do Female Athletes Return to Sports After Hip Preservation Surgery for Femoroacetabular Impingement Syndrome?: A Comparative Analysis. BMI, FAIS, HOS-ADL, HOS-SS, MCID, mHHS, PROs, VAS
2019 Efficacy of a Second-Generation Rotating Bearing Tibial Platform in Total Knee Arthroplasty: A Prospective Observational Cohort Study with Registry Analysis. AOANJRR, MCID, OKS, RBK, TKA, UKA
2019 Establishing clinically significant outcome after arthroscopic rotator cuff repair. ASES, MCID, RCR, SANE, SCB
2019 Establishing Clinically Significant Outcomes After Meniscal Allograft Transplantation. BMI, IKDC, KOOS, MAT, MCID, PROMs, QOL, SF PCS
2019 Establishing minimal clinically important difference, substantial clinical benefit, and patient acceptable symptomatic state after biceps tenodesis. BT, MCID, SANE, SCB
2019 Factors Associated With Clinically Significant Patient-Reported Outcomes After Primary Arthroscopic Partial Meniscectomy. ADL, IKDC, JR, KOOS, MCID, PF, QOL, SCB
2019 Minimum Clinically Important Difference and Patient Acceptable Symptom State of Japanese Orthopaedic Association Score in Degenerative Cervical Myelopathy Patients. JOA, MCID, MDC, mJOA, ROC, SD
10  2019 Patient acceptable symptom state and minimal clinically important difference for patient-reported outcomes in systemic sclerosis: A secondary analysis of a randomized controlled trial comparing personalized physical therapy to usual care. MCID, SSc
11  2019 Patient-reported health outcomes for severe knee osteoarthritis after conservative treatment with an intra-articular cell-free formulation for articular cartilage regeneration combined with usual medical care vs. usual medical care alone: A randomized controlled trial. MCII, OA, RPCEC
12  2019 Physical activity level and association with behavioral factors in knee osteoarthritis. BMI, IPAQ, MET, OA, PA
13  2019 Predictive Factors and Duration to Return to Sport After Isolated Meniscectomy. IKDC, KOOS, MCID, PS, RTS
14  2019 Predictive Factors and the Duration to Pre-Injury Work Status Following Biceps Tenodesis. ASES, AUC, CMS, SANE
15  2019 Preoperative and Intraoperative Predictors of Long-Term Acceptable Knee Function and Osteoarthritis After Anterior Cruciate Ligament Reconstruction: An Analysis Based on 2 Randomized Controlled Trials. ACL, CI, OA, OR
16  2019 Prospective Evaluation of the Patient Acceptable Symptom State to Identify Clinically Successful Anterior Cruciate Ligament Reconstruction. ACLR, KOOS
17  2019 Relationship Between Health-Related Quality of Life and Patient Acceptable Symptom State With Disease Activity and Functional Status in Patients With Ankylosing Spondylitis in Thailand. AS, EQ-5D, HU
18  2019 The Patient Acceptable Symptomatic State of the 12-Item International Hip Outcome Tool at 1-Year Follow-Up of Hip-Preservation Surgery. SD
19  2018 Clinically Meaningful Improvements After Hip Arthroscopy for Femoroacetabular Impingement in Adolescent and Young Adult Patients Regardless of Gender. ADL, FAI, HOS, MCID, MHHS, SS
20  2018 Determining Success or Failure After Foot and Ankle Surgery Using Patient Acceptable Symptom State (PASS) and Patient Reported Outcome Information System (PROMIS). ANOVA, PF, PI, PROMIS, PROs, ROC
21  2018 Development of the HOOSglobal to Assess Patient-Reported Outcomes in Patients Undergoing Hip Preservation Procedures. OA, PAO, PRO, THA
22  2018 Does Iliopsoas Lengthening Adversely Affect Clinical Outcomes After Hip Arthroscopy? A Multicenter Comparative Study. FAI, IFL, MCID, PROs, THA
23  2018 DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture. DC, DETECT
24  2018 Factors Affecting the Achievement of a Patient-Acceptable Symptom State 1 Year After Anterior Cruciate Ligament Reconstruction: A Cohort Study of 343 Patients From 2 Registries. ACL, KOOS, QOL
25  2018 Getting Better or Getting Well? The Patient Acceptable Symptom State (PASS) Better Predicts Patient's Satisfaction than the Decrease of Pain, in Knee Osteoarthritis Subjects Treated with Viscosupplementation. OA, PGAP, PROs, WOMAC
26  2018 Hip Arthroscopic Surgery for Femoroacetabular Impingement With Capsular Management: Factors Associated With Achieving Clinically Significant Outcomes. FAI, HOS, MCID, mHHS, SSS
27  2018 Identification of a Patient Acceptable Symptomatic State Score for the International Hip Outcome Tool in People Undergoing Hip Arthroscopy. CI, OR, ROC
28  2018 In Search of the Spherical Femoroplasty: Cam Overresection Leads to Inferior Functional Scores Before and After Revision Hip Arthroscopic Surgery. FAI, mHHS, NAHS, THA
29  2018 Patient Acceptable Symptom State in Knee Osteoarthritis Patients Succeeds Across Different Patient-reported Outcome Measures Assessing Physical Function, But Fails Across Other Dimensions and Rheumatic Diseases. OA, PROM
30  2018 Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis. HAQ-DI, TCZ
31  2018 Patient-Reported Outcomes of Capsular Repair Versus Capsulotomy in Patients Undergoing Hip Arthroscopy: Minimum 5-Year Follow-up-A Matched Comparison Study. MCID, mHHS, PROs
32  2018 Periarticular Injection Versus Femoral Nerve Block for Pain Relief After Anterior Cruciate Ligament Reconstruction: A Randomized Controlled Trial. ACL, FNB, MCID, PI, VAS
33  2018 Select Biomarkers on the Day of Anterior Cruciate Ligament Reconstruction Predict Poor Patient-Reported Outcomes at 2-Year Follow-Up: A Pilot Study. ACL, IKDC, KOOS, MMP-9, QOL, SF
34  2018 The Effectiveness of Platelet-Rich Plasma Injections in Gluteal Tendinopathy: A Randomized, Double-Blind Controlled Trial Comparing a Single Platelet-Rich Plasma Injection With a Single Corticosteroid Injection. MCID, mHHS, PRP
35  2018 The Influence of Pain in Other Major Joints and the Spine on 2-Year Outcomes After Hip Arthroscopy. HOS-ADL, MCID, MSM
36  2018 Validity and Internal Consistency of the New Knee Society Knee Scoring System. ADL, KOOS, KSS
37  2017 A Comparison of Clinical Outcomes After Unilateral or Bilateral Hip Arthroscopic Surgery: Age- and Sex-Matched Cohort Study. BMI, FAI, HOS-ADL, HOS-SS, MCID, mHHS
38  2017 Associations Between Five Important Domains of Health and the Patient Acceptable Symptom State in Rheumatoid Arthritis and Psoriatic Arthritis: A Cross-Sectional Study of 977 Patients. PsA, RA
39  2017 Effects of manual therapy and exercise targeting the hips in patients with low-back pain-A randomized controlled trial. GROC, LBP, LBP
40  2017 Measuring acute postoperative pain using the visual analog scale: the minimal clinically important difference and patient acceptable symptom state. MCID, VAS
41  2017 Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT). ACR, CONCEPT, ITT, LI, MCII, OA, VAS
42  2017 Physical fatigue characterises patient experience of primary Sjogren's syndrome. pSS
43  2017 Stepped care approach for medial tibiofemoral osteoarthritis (STrEAMline): protocol for a randomised controlled trial. BMI, OA
44  2017 The Influence of Body Mass Index on Outcomes After Hip Arthroscopic Surgery With Capsular Plication for the Treatment of Femoroacetabular Impingement. BMI, FAI, HOS, mHHS, VAS
45  2017 Total knee replacement: Are there any baseline factors that have influence in patient reported outcomes? EFA, MCID, TKR
46  2016 Cervicothoracic Manual Therapy Plus Exercise Therapy Versus Exercise Therapy Alone in the Management of Individuals With Shoulder Pain: A Multicenter Randomized Controlled Trial. GROC, SPADI
47  2016 Defining disease activity states and clinically meaningful improvement in primary Sjogren's syndrome with EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). ESSDAI, ESSPRI, EULAR, MCII, SS
48  2016 Defining Thresholds for the Patient Acceptable Symptom State for the IKDC Subjective Knee Form and KOOS for Patients Who Underwent ACL Reconstruction. ACL, ADL, IKDC-SKF, KOOS, PRO, QOL
49  2016 Determination of the Oswestry Disability Index score equivalent to a "satisfactory symptom state" in patients undergoing surgery for degenerative disorders of the lumbar spine-a Spine Tango registry-based study. AUC, COMI, ROC, Se, Sp
50  2016 Hip Arthroscopy Outcomes With Respect to Patient Acceptable Symptomatic State and Minimal Clinically Important Difference. HOS, MCID, mHHS
51  2016 How much does the Dallas Pain Questionnaire score have to improve to indicate that patients with chronic low back pain feel better or well? DPQ, LBP, MCII
52  2016 The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis. AS, BASDAI, BASFI, MCII
53  2016 What PASSes for good? Experience-based Swedish and hypothetical British EuroQol 5-Dimensions preference sets yield markedly different point estimates and patient acceptable symptom state cut-off values in chronic arthritis patients on TNF blockade. CUAs, EQ-5D, HRQoL, PsA, QALYs, RA, SE, SpA, TNF
54  2015 Clinical improvement and satisfaction after total joint replacement: a prospective 12-month evaluation on the patients' perspective. EQ-5D, PROMs, TJR, UCLA
55  2015 Defining patient acceptable symptom state thresholds for commonly used patient reported outcomes measures in general orthopedic practice. ---
56  2015 Development of multinational definitions of minimal clinically important improvement and patient acceptable symptomatic state in osteoarthritis. AUSCAN, MCII, OA, WOMAC
57  2015 Measurement properties of the smartphone-based B-B Score in current shoulder pathologies. MCII, MDC
58  2015 Patient Acceptable Symptom State in Self-Report Questionnaires and Composite Clinical Disease Index for Assessing Rheumatoid Arthritis Activity: Identification of Cut-Off Points for Routine Care. CDAI, PRO-CLARA, PROs, RA, RAID, ROAD, ROC
59  2015 The Patient Acceptable Symptomatic State for the Modified Harris Hip Score and Hip Outcome Score Among Patients Undergoing Surgical Treatment for Femoroacetabular Impingement. FAI, HOS, mHHS
60  2014 A complex of three natural anti-inflammatory agents provides relief of osteoarthritis pain. MCII, OA, PGA, RGA, VAS
61  2014 Concordance between important change and acceptable symptom state following knee arthroplasty: the role of baseline scores. CI, MCID, TKA, WOMAC
62  2014 Crenobalneotherapy (spa therapy) in patients with knee and generalized osteoarthritis: a post-hoc subgroup analysis of a large multicentre randomized trial. MCII
63  2014 Minimal clinically important improvement (MCII) and patient-acceptable symptom state (PASS) in total hip arthroplasty (THA) patients 1 year postoperatively. HOOS, HOOS Pain, MCII, MCIIs, PASSs, PROs, THA
64  2014 Patient acceptable symptom states after totalhip or knee replacement at mid-term follow-up: Thresholds of the Oxford hip and knee scores. NRS, OHS, OKS, ROC, THR, TKR
65  2014 The addition of cervical unilateral posterior-anterior mobilisation in the treatment of patients with shoulder impingement syndrome: a randomised clinical trial. SD, SIS
66  2014 The impact of preoperative patient characteristics on health states after total hip replacement and related satisfaction thresholds: a cohort study. CER, HRQoL, THR
67  2013 "Feeling better" or "feeling well" in usual care of hip and knee osteoarthritis pain: determination of cutoff points for patient acceptable symptom state (PASS) and minimal clinically important improvement (MCII) at rest and on movement in a national multicenter cohort study of 2414 patients with painful osteoarthritis. HOA, KOA, MCII
68  2013 Criterion validation of the rate of recovery, a single alphanumeric measure, in patients with shoulder pain. NPRS, ROC, RoR
69  2013 Evaluation of spondylarthritis activity by patients and physicians: ASDAS, BASDAI, PASS, and flares in 200 patients. ASDAS, BASDAI, BASFI, CRP, ROC
70  2013 Evaluation of the patient acceptable symptom state (PASS) in Italian patients affected by systemic lupus erythematosus: association with disease activity indices. SLE
71  2013 Identification of cut-points in commonly used hip osteoarthritis-related outcome measures that define the patient acceptable symptom state (PASS). OA, WOMAC
72  2013 Relative importance of doctor-reported outcomes vs patient-reported outcomes in DMARD intensification for rheumatoid arthritis: the DUO study. DROs, PROs
73  2013 The influence of the contralateral knee prior to knee arthroplasty on post-arthroplasty function: the multicenter osteoarthritis study. WOMAC
74  2012 Clinically relevant outcomes based on analysis of pooled data from 2 trials of duloxetine in patients with knee osteoarthritis. MCII, NNT, OA
75  2012 Evaluation and stability of the Patient Acceptable Symptom State (PASS) over time in patients with ankylosing spondylitis. ---
76  2012 Evaluation of the Iranian versions of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis. AS, BAS-G, BASDAI, BASFI, ICC
77  2012 Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study. MCII
78  2012 Outcomes after total hip replacement based on patients' baseline status: what results can be expected? MCID, ROC, THR, WOMAC
79  2012 Patient acceptable symptom state and OMERACT-OARSI set of responder criteria in joint replacement. Identification of cut-off values. ROC, THR, TKR, WOMAC
80  2012 Predictors of outcomes of total knee replacement surgery. OKS, TKR
81  2011 Identification of shoulder-specific patient acceptable symptom state in patients with rheumatic diseases undergoing shoulder surgery. DASH, OR, VAS
82  2011 Validation of a numerical rating scale to assess functional impairment in hip and knee osteoarthritis: comparison with the WOMAC function scale. ES, MCII, NRS, NSAIDs, OA, SRM
83  2010 Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. AS, DMARD, EQ-5D, MCII, PsA, RA, ROC, SF-6D
84  2010 The minimally important difference and patient acceptable symptom state for the Raynaud's condition score in patients with Raynaud's phenomenon in a large randomised controlled clinical trial. MID, RCS, RCT, RP
85  2010 Thresholds of patient-reported outcomes that define the patient acceptable symptom state in ankylosing spondylitis vary over time and by treatment and patient characteristics. AS, ASAS20, PRO
86  2009 Minimal clinically important differences (MCID) and patient acceptable symptomatic state (PASS) for visual analog scales (VAS) measuring pain in patients treated for rotator cuff disease. MCID, VAS
87  2009 Patient acceptable symptomatic state (PASS). ---
88  2009 Safety, efficacy and predictive factors of efficacy of a single intra-articular injection of non-animal-stabilized-hyaluronic-acid in the hip joint: results of a standardized follow-up of patients treated for hip osteoarthritis in daily practice. FU, HOA, MCII, NASHA, PGA, WP
89  2009 The variability in minimal clinically important difference and patient acceptable symptomatic state values did not have an impact on treatment effect estimates. ES, MCID, SD
90  2008 Does joint effusion influence the clinical response to a single Hylan GF-20 injection for hip osteoarthritis? ---
91  2008 Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: data from a randomized controlled trial. AS
92  2008 Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis. CDAI, PAS, SDAI
93  2008 Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis. ACR, ARA, EULAR, RA
94  2008 Six-month response to anti-TNF drugs in axial spondylarthropathy according to the fulfillment or not of New-York criteria for ankylosing spondylitis or French recommendations for anti-TNF use. A "real life" retrospective study on 175 patients. AS, NY, SpA
95  2008 [Chronic low back pain and functional restoring program: applicability of the Patient Acceptable Symptom State]. FRP
96  2007 Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis. BASFI, QOL
97  2007 Evaluation of the patient acceptable symptom state in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis. OA, WOMAC LK 3.1
98  2007 Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders. MCII, SIG
99  2007 Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean? MCID, MCII, MCII/MCID, ROC
100  2006 Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis. AS, BASDAI, BASFI, VAS